
Bimatoprost improves facial vitiligo treatment outcomes. A clinical trial on 38 patients compared 308-nm excimer laser monotherapy to combination therapy with bimatoprost 0.03%. The intervention group showed a significant VASI score increase (p ≤ 0.001) and improved VASS and SAI outcomes. Side effects were minimal, with mild hypertrichosis and erythema in some cases. These findings suggest bimatoprost enhances treatment efficacy in vitiligo-resistant patients.
Like
Save
Share